HighTower Advisors
MDCO

HighTower Advisors’s Medicines Co MDCO Stock Holding History

HighTower Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,277
Closed -$215K – 2615
2019
Q3 		$215K Buy
+4,277
New +$171K ﹤0.01% 2022
2018
Q1 		– Sell
-7,609
Closed -$206K – 2394
2017
Q4 		$206K Buy
7,609
+422
+6% +$13K ﹤0.01% 1911
2017
Q3 		$266K Buy
7,187
+433
+6% +$16K ﹤0.01% 1747
2017
Q2 		$258K Buy
6,754
+941
+16% +$41.9K ﹤0.01% 1718
2017
Q1 		$284K Buy
+5,813
New +$265K ﹤0.01% 1586
2015
Q3 		– Sell
-7,259
Closed -$208K – 1981
2015
Q2 		$208K Sell
7,259
-1,341
-16% -$37.4K ﹤0.01% 1342
2015
Q1 		$241K Buy
+8,600
New +$242K ﹤0.01% 1349

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

HighTower Advisors's MDCO Position: Q4 2019 in Review

HighTower Advisors sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 4,277 shares — an estimated $215K sold.

HighTower Advisors first reported a position in MDCO in Q1 2015 and held it in 7 quarters. The position peaked at $284K in Q1 2017. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • HighTower Advisors reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • HighTower Advisors sold 4,277 Medicines Co shares in Q4 2019, an estimated $215K.
  • HighTower Advisors first reported a position in Medicines Co in Q1 2015 and held it in 7 quarters.
  • HighTower Advisors's Medicines Co position peaked at $284K in Q1 2017.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on HighTower Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.